ABSTRACT-The inhibitory actions of the selective dopamine D1 and D2-antagonists SCH 23390 and YM 09151-2, respectively, on the mouse's discrete shuttle avoidance were almost equipotent at doses ranging from 0.01-0.1 mg/kg. SCH 23390 reduced the stimulant action of methamphetamine (0.5 mg/kg), MK-801 (0.1 mg/kg) and ketamine (10 mg/kg) with a similar potency. YM-09151-2 also antagonized the actions of these drugs, with the following order of effectiveness: ketamine > MK-801 > methamphetamine. The pres ent results indicate that methamphetamine, MK-801 and ketamine have different characteristics of CNS stimulant action through dopamine D2-receptors.
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The non-competitive NMDA antagonist MK-801
(dizocilpine) and the dissociative anesthetic ketamine have behavioral stimulant actions: they increase the am bulatory (locomotor) activity at a comparatively lower dose, and they induce stereotypy at a higher dose in ro dents (1 -4) , producing an ipsilateral turning in rats hav ing 6-OHDA-induced unilateral nigrostriatal lesion (5, 6) . These findings indicate that both MK-801 and ketamine indirectly stimulate the central dopaminergic systems. Neurochemical investigations have also demonstrated that MK-801 or ketamine causes an increase in the dopa mine release from presynaptic dopaminergic neurons (6, 7); this action is similar to that of methamphetamine (8) .
However, there are some characteristic differences among these drugs. The ambulation-increasing effect of metham phetamine and ketamine can be inhibited by a-methyl p tyrosine, whereas that of MK-801 is inhibited by reserpine (3, 4, 9) . In this study, we further evaluated the characteristics of the CNS stimulant effects of methamphetamine, MK-801 and ketamine through combined administration with the selective dopamine D1 and D2-antagonists SCH 23390 (10, 11) and YM-09151-2 (12), respectively, by means of discrete shuttle avoidance in mice. Shuttle avoidance has been empirically considered to be convenient for detect ing both the behavioral stimulant and depressant actions of drugs (13) .
Male mice of the ddY strain (Japan Laboratory Ani mals, Tokyo) were used from the age of 8 weeks. Through out the experiment, these mice were kept in a controlled room (12-hr light-dark schedule with a light period of 6:00 -18:00, temperature of 22 ± 1 °C , and relative humidi ty of 50±2%) with free access to food and tap water.
The drugs used were methamphetamine HCl (Philo pon, Dainippon Pharm., Osaka), MK-801 hydromaleate (dizocilpine, Merck/Banyu, Tokyo), ketamine HCl (Keta lar, Sankyo, Tokyo), SCH 23390 (Research Biochem., Natick, MA, USA), and YM-09151-2 (Yamanouchi Pharm., Tokyo). YM-09151-2 was first dissolved in a small amount of 1 N HCl solution, and then the solution was diluted with physiological saline. The other drugs were dissolved or diluted with the saline. The drugs were administered s.c. at a fixed volume of 0.1 ml/10 g body weight regardless of the doses. The present experiment was run with the shuttle box, behavior-controlling and data-recording units (GT-8450, De CARES GT-M5 and TIDP-10, respectively; O'Hara & Co., Tokyo). The temporal parameters of the discrete avoidance schedule were an intertrial interval of 25 sec and a warning period (indicated by an 800-Hz tone signal) of 5 sec. An electric current (100 V, 0.3 mA, 50 Hz AC) was presented for 0.3 sec to the mouse's feet through the floor grid of the chamber when the mouse failed to make an avoidance response (shuttle) during the warning period. The indices of the avoidance behavior were the response rate (frequency of shuttles) and the % avoid ance (avoidance responses/avoidance trials). Methamphetamine, MK-801 and ketamine were ad ministered immediately before the avoidance session of 30 min, in which 60 avoidance trials were held at intervals of 30 sec. The animals were treated with SCH 23390 or YM-09151-2 20 min prior to the avoidance session. The drug-testing sessions were run at intervals of 3-4 days, and the days before saline was administered as the control and/or baseline sessions. Three groups of 10 mice each were trained and used for the experiments as follows: the 1st group was used to evaluate the effects of the single administration of SCH 23390 and YM-09151-2 and the other groups were used to test the effects of combining SCH 23390 (2nd group) or YM-09151-2 (3rd group) with methamphetamine, MK-801 and ketamine. The orders of evaluation of methamphetamine, MK-801 and ketamine were randomized among the mice. However, in each drug evaluation, the doses of SCH 23390 and YM-09151-2 ad ministered were changed from lower to higher in the 5 mice and changed in the reverse order in the other 5 mice.
All the experiments were held between 9:00-14:00.
The 30-min overall response rate and the 076 avoidance were first analyzed by ANOVA, followed by the individ ual comparisons by Dunnett's test. When the P value was equal to or less than 0.05, the two values were considered to be significantly different.
As shown in Fig. 1 , SCH 23390 and YM-09151-2 in hibited the avoidance behavior. Thus, both drugs sig nificantly decreased the response rate at 0.01 mg/kg and the % avoidance at 0.03 mg/kg. There was no significant difference in the avoidance-inhibitory actions of SCH 23390 and YM-09151-2.
As shown in Fig. 2 , methamphetamine (0.5 mg/kg), MK-801 (0.1 mg/kg) and ketamine (10 mg/kg) almost equivalently enhanced the avoidance behavior; increasing the response rate to 2.2-2.5 times as high as those of the corresponding saline-administered baseline level. SCH 23390 inhibited the effects of methamphetamine, MK-801 and ketamine with almost the same dose-effect relation ships for both the response rate and the 016 avoidance (left panel). YM-09151-2 also antagonized the actions of these 3 drugs, with the following decreasing order of effective ness: ketamine > MK-801 > methamphetamine.
The present experiment confirmed the neuroleptic ac tion of SCH 23390 and YM-09151-2: inhibiting the dis crete avoidance response and showing anti-amphetamine action. The avoidance-inhibiting actions of both SCH 23390 and YM-09151-2 were completely reversible, and the pre-drug baseline avoidance response was re-estab lished by the day after drug administration. Such results indicate that the avoidance-inhibition is not produced through learning and memory processes. Although it has been considered that the neuroleptic activities of drugs are correlated with the blockade action on the dopamine D2-receptors (14) , the present results in dicate that the blockade of either D1 or D2-receptors is sufficient for exhibiting the neuroleptic actions. Similar results have been also demonstrated elsewhere (10, 11) . Furthermore, the dose-effect relationships obtained in this experiment indicate that the avoidance-suppressing actions are almost equipotent between SCH 23390 and YM-09151-2 when they are administered singly.
On the other hand, the response-increasing effects of methamphetamine (0.5 mg/kg), MK-801 (0.1 mg/kg) and ketamine (10 mg/kg) were almost the same, and these effects could be antagonized dose-dependently by SCH 23390 and YM-09151-2. The antagonistic actions of SCH 23390 were almost identical among methamphetamine, MK-801 and ketamine, suggesting that there is no remark able difference in the actions of these drugs through dopa mine D1-receptor systems. However, taking into account the results of the present study, it is considered that there are characteristic differences in the CNS stimulant actions of the 3 drugs in terms of their effect on the dopamine D2 receptor systems. Thus, the dose-effect relationships rev ealed that, although the potencies of the avoidance-sup pressing effect as well as the antagonistic actions for keta mine were almost the same between SCH 23390 and YM 09151-2, the antagonistic actions of YM-09151-2 against methamphetamine and MK-801 were about 1/10 and 1/3, respectively, as high as that for ketamine. We have report ed that the stimulant effects of comparatively lower doses of MK-801 and ketamine are selectively reduced by reser pine and a-methyl p-tyrosine, respectively (3, 4) , indicat ing that the properties of ketamine, but not MK-801, are very similar to those of methamphetamine (8) . However, such differences in properties are inadequate for explain ing the differential dose-effect relationships for the interac tions of these 3 drugs with YM-09151-2. Methampheta mine, but not MK-801 and ketamine, has an inhibitory ac tion on dopamine reuptake at presynaptic terminals (8) , whereas MK-801 and ketamine, but not methampheta mine, possess non-competitive NMDA antagonistic ac tion as well as agonistic action on sigma-receptors (1, 9).
Moreover, the methamphetamine-induced change in the monoamine synthesis at presynaptic neurons (15) may be differentially responsible for the actions of dopamine D, and D2-antagonists (2, 10). Such differences may result in YM-09151-2 having a weaker antagonistic action than SCH 23390 on the stimulant effect of methamphetamine. 
